Eu Yan Sang to be acquired by Japan’s Mitsui, Rohto Pharmaceutical for S$800mil

Eu Yan Sang

SINGAPORE: Two Japanese firms are outlaying US$594 million (S$800 million) to buy out local traditional Chinese medicine maker Eu Yan Sang.

Japanese trading house Mitsui & Co announced on April 4 that a special purpose entity it has set up with Rohto Pharmaceutical will buy around 86 per cent of Eu Yan Sang from Righteous Crane Holding.